The value of leucocyte excretion rates in determining "at risk" patient with asymptomatic bacilluria.
D000667:Ampicillin / Q000627:therapeutic use; D001437:Bacteriuria / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy; D001724:Birth Weight; D005260:Female; D005313:Fetal Death; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D007234:Infant, Premature; D007962:Leukocytes; D009268:Nalidixic Acid / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis*; D011704:Pyelonephritis / Q000000981:diagnostic imaging; D013444:Sulfisoxazole / Q000627:therapeutic use; D014556:Urine / Q000166:cytology*; D014567:Urography
D009268:Nalidixic Acid; D013444:Sulfisoxazole; D000667:Ampicillin; D009582:Nitrofurantoin